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Background: The need has grown over recent years for economic information on the 
impacts of child and adolescent mental helath problems and the cost-effectiveness of 
interventions. Methods: A range of electronic databases were searched using a 
predefined search strategy. To identify economic studies which focused on services, 
pharmacological interventions and other treatments for children and adolescents with 
a diagnosed mental health problem or identified as at risk of mental illness. Published 
studies were included in the review if they assessed both costs and outcomes, with 
cost-effectiveness being the primary interest. Articles meeting the criteria for 
inclusion were assessed for quality. Results: Behavioural disorders have been given 
relatively large attention in economic evaluations of child and adolescent mental 
health. These studies tentatively suggest child behavioural gains and parent 
satisfaction from parent and child training programmes, however the cost 
effectiveness of the location of delivery for behvaioural therapies is less clear. In 
general the quality of economic evaluations was limited by small sample sizes, a 
narrow conceptualisation of costs, narrow perspectives and limited statistical and 
econometric methods. Conclusion: Economic evaluations in the field of child and 
adolescent mental health services are few in number and generally poor in quality, 
although the number of studies being undertaken is now rising relatively quickly. 
Keywords: adolescence, behavioural interventions, childhood, depressive disorder, 
developmental disorder, mental health, parent training, pharmacotherapies, psychosis, 
substance abuse, economic evaluations, costs. Abbreviations: ADHD: attention 
deficit hyperactivity disorder; CAMHS: child and adolescent mental health services; 
QALY: Quality Adjusted Life Year; CEMH: Centre for Economics of Mental Health. 




Developments in mental health interventions for children and adolescents have 
improved the effectiveness of treatment in terms of symptoms, behaviour, personal 
functioning, educational attainment and other needs related dimensions. But achieving 
greater effectiveness, fundamental though that must be, is not enough. Decision 
makers also beed to know whether those outcome gains are ‘worth it’: are they cost-
effective? 
 
In an effort to obtain the best value from decisions about service delivery, 
pharmacological treatments and other interventions, there have been increasing calls 
for economic analysis. The high cost of many mental health problems in childhood 
and adolescence has been evidenced in various studies around the world such as 
Julian et al, 1992 and Jackson 1996 . These studies emphasise the economic impact 
for families, the health services and other agencies of the of morbidity of mental 
illness in children and adolescents. Although these studies provide important 
information about the description of services and costs of mental disorders in young, 
they do not provide insight into which interventions are relatively the most efficient in 
providing the best outcomes for given expenditures of resources.  Given the high 
levels of demand for services, technology and treatments, and the high personal and 
social costs associated with mental health problems, evidence on the relative value of 
different service interventions and treatments becomes necessary. By assembling, 
assessing and comparing the costs, health effects and quality of life improvements of 
interventions, economic evaluation provides decision makers at all levels within a 
care system with information to help them make best value judgements.  
 
The aim of this study was to review the economic evaluation literature in the child 
and adolescent mental health area. We systematically obtained and reviewed all 






An electronic search was conducted in June 2001 on Medline (1966 to 2001), 
PsychINFO (1967 to 1983, and 1984 to March 2001) and EMBASE (1980 to 2001). 
These searches were updated in July 2002 on Medline (2001 to June week 2 2002), 
PsychINFO (2001 to May week 5 2002) and EMBASE (January 2001 to June week 2 




For inclusion in the review, studies or papers needed to meet the following criteria: 
 
•  focused primarily on children aged 18 or under; 
•  focused on a diagnosable psychiatric problem or disorder, whether present or 
at risk; 
•  focused on psychotherapies, pharmacotherapies, service arrangements or 
policies; and  
•  Assessment of costs alongside outcomes or costs and savings. 





The exclusion criteria follow from the above list, but we particularly sought to 
exclude: 
 
•  studies of interventions aimed at parents of children with mental health 
problems; 
•  studies of adults diagnosed with mental illness who had childhood problems; 
and 
•  studies of non-health care interventions (for example, school-based 
interventions) unless one of the main objectives was to improve the mental 
health of particular subgroups of children (pupils). 
 
Three reviewers (RR, SB, and MK) screened abstracts of all papers identified by the 
search and judged the eligibility of articles from the abstract. Where there was 
uncertainty about inclusion of an article or there was no abstract on which to make a 




A data extraction sheet was designed to collect information on the following aspects 
of each study: type of intervention, type of mental health problem, type of economic 
evaluation, range of costs included, study perspective (e.g. societal, health service, 
public sector or child and family), outcome measures, sample size, study design, 
statistical analysis, sensitivity analysis and generalizability. Table1 summarises the 
basic aspects of each of the studies identified as economic evaluations.  
 
Assessment of quality 
 
To assess the quality of the economic evaluations, we referred to the ten-point 
checklist suggested by Drummond et al (1997), summarised in Box 1. Each paper was 
read by one author (the papers equally shared between the authors) and a summary 
and commentary drafted. A second author then read the paper and discussed changes 
to the structured account with the co-authors. 
 




In this section general remarks will be followed by more specific observations on the 




The search identified a total of 1615 references, of which 56 studies appeared to meet 
our inclusion criteria and were extracted for review. On review of the full articles, a 
further 35 studies were subsequently found not to be eligible for inclusion and were 
excluded. The 21 included studies were all published in English between 1980 to 
2002. Nine (43%) of the studies were from the US. Four (19%) were from the UK, 
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four (19%) from Canada and the rest from Australia, Sweden, Norway and the 
Netherlands.   
 
Of the 21 studies located, 14 included assessments of both costs and outcomes of two 
or more interventions. These studies differed in the way effectiveness was expressed, 
which made it difficult to compare across studies. Most were cost-effectiveness 
analyses which compared costs and outcomes measured on disease-specific scales for 
symptoms, behaviour, parent child interaction, parent’s sense of competence and 
functioning. Cost-utility analysis, involving the measurement of costs and 
measurement of outcomes in terms of the summary indicator, quality-adjusted life 
years, was only undertaken in one study. No cost-benefit analyses, measuring costs 
and outcomes in monetary terms, were located.  
 
Seven studies, although variously referred to by the authors as cost-benefit, cost-
effectiveness or cost-minimisation analyses, were in fact more appropriately classified 
as cost-offset studies. Cost-offset studies compare costs incurred with costs saved. 
These studies ignore child-focused outcomes such as changes in clinical status or 
quality of life, and as a result cannot provide insight into the efficiency with which the 
resources are deployed, that is they do not assess cost-effectiveness. For this reason 
they cannot be classified as economic evaluations. However, there is not always an 
unambiguous division between costs and outcomes, for savings that result from 
reduced service use are likely to result from reduced individual needs, which can 
obviously also be called outcomes. Moreover, some outcomes might be proxied by 
changes in service use – a good example being reduced antisocial behaviour measured 
by a reduction in crime. It is only a small step from there to measurement in cost 
terms of reductions in the criminal justice and societal implications of crime. 
 
Table 1 summarises the basic characteristics of all the studies included in terms of the 
type of economic evaluation, the problem under study, the intervention(s) examined, 
the costs and outcomes measured and the main findings. Where the type of economic 





Eight of the fourteen economic evaluations focused on behavioural disorders or 
antisocial behvaviour. One evaluated a drug treatment for hyperactive children 
(Gilmore & Milne, 2001), while three others examined alternative behavioural 
techniques (Christensen et al, 1980; Jones & Offord, 1989; Thompson et al, 1996). 
Four studies evaluated the location of services (Cunningham et al, 1995; Grizenko & 
Papineau, 1992; Harrington et al, 2000; Slot et al, 1992). 
 
In the study looking at pharmacotherapies as a treatment for hyperactivity in children, 
Gilmore and Milne (2001) estimated the cost per quality-adjusted life year (QALY). 
Of the papers that meet our inclusion criteria, this is the paper included in the review 
which combines costs with quality of life in a cost-utility analysis. The cost per 
QALY derived by the authors (£7,446-£9,177) depending on the severity of the 
disorder) was stated to compare favourably with other treatments currently available. 
However the methodology used has been debated (Freemantle & Mason, 1999; 
Campbell et al, 1999).  
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Three studies evaluated alternative behavioural therapeutic interventions (Christensen 
et al, 1980; Jones & Offord, 1989; Thompson et al, 1996). Both Christensen and 
Thompson measured costs narrowly in terms of professsionals’ time. A range of 
outcome measures was used, including parent perception of problem behaviour, 
overall satisfaction with family relationships (Thompson et al 1996), reduction in 
problem behaviours (Christensen et al 1980), skill development, integration, self-
esteem and behaviour at home and school, and community measures of antisocial 
behaviour (police charges, secuirty violations, fire calls) (Jones & Offord, 1989). 
 
The findings of the Christensen study of behavioural family therapy indicate that, 
compared to controls, the parents who completed the therapeutic training programmes 
reported improvements in their child’s externalising behaviour, more satisfaction and 
efficacy for parents and more satisfaction in family relationships in general. At 
treatment termination, the authors indicate that those receiving minimal contact 
bibliotherapy spent less time (5 hours) with the professional than those in individual 
treatment (11 hours). There were also significantly larger reductions in problem 
behaviours under clinical conditions. Although limited in its narrow range of costs 
and small sample size, the study provides valuable information in an under researched 
area.  
 
Thompson et al (1996) found that parent training for those who completed the 
programme resulted in greater satisfaction in family relationships than controls. The 
additional direct cost per family was estimated at $70 (£44). The authors admit that 
the results are limited due to non-random allocation to treatment, the narrow 
conceptualisation of costs, lack of a clear perspective and lack of discussion of the 
economic issues associated with use of one treatment over another. 
 
The focus of the Jones & Offord (1989) study was non-school skill development to all 
children aged 5-15 living in a publicly-supported housing complex. Experimental and 
control housing complexes were compared over three years. Data on costs and 
potential savings were measured. Significant improvements were found in antisocial 
behaviour outside home and school, but there were no spillover effects on school 
performance or behaviour at home. Costs were only measured for the intervention 
programme. A cost-offset analysis found that programme expenditure was 
substantially smaller than savings. 
 
Two other Canadian studies evaluated the location of services for young people with 
behavioural disorders (Grizenko & Papineau, 1992; Cunningham et al, 1995). 
Grizenko & Papineau (1992) compared the costs and effects of a residential unit in a 
psychiatric hospital with a day treatment programme. The findings indicate that each 
treatment group showed a significant improvement in the level of school integration. 
Costs of the day treatment group were significantly less than for the residential group. 
The authors point out a number of methodological weaknesses of the study associated 
with the overall design and costing methods.  
 
Cunningham and colleagues (1995) assessed the cost-effectiveness of a large 
community-based group training programme compared to a clinic-based individual 
intervention.  Outcome measures included adherence, behaviour problems at home 
and the child’s behaviour.  Cost measures were based on the programme costs, which 
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included the direct cost of the programme and use of educational and health care 
resources.  Between pre- and post-test, community groups tended to report greater 
additional gains than individual participants.  The total cost per participant was 
marginally lower for the individual programme compared to the community group.  A 
review by the Cochrane Database argued that the conclusions of the authors appear 
justified given the data, although generalisibility of the results to other settings have 
not been discussed.  
 
In the Netherlands, Slot et al (1992) compared a residential-based teaching family 
model of care to a traditional state institute for antisocial behaviour. Fifty-seven 
young people from the state institute were matched by age with young people treated 
by the teaching family model. No differences were found between the two groups in 
terms of problems or ability to form relationships outside the family, but young 
people in the state institute showed improvement in community participation ability, 
whilst those in the teaching family model showed no change. The teaching family 
model was much less costly than the state institute. This very simple study was 
hindered by a narrow cost perspective, small sample, limited matching and limited 
statistical analyses. 
 
In the UK, Harrington et al (2000) compared community-based with hospital-based 
parent education groups for children with behavioural disorders in a randomised 
controlled trial. Their findings suggest no differences in either outcomes or costs 
between the two groups.  The authors also suggest that the sample size, determined on 
the basis of outcomes, may have been too small to detect a statistically significant 
difference in cost. 
 
The only cost offset study in this diagnostic group was conducted by Bagley and 
Pritchard (1998), where the “impact” measure assessed included cost savings as a 
result of reductions in school exclusions. The results suggest that the reduction in 




Two of the fourteen economic evaluations focused on the evaluation of interventions 
for treating children with depressive illnesses. One involved an assessment of 
electroconvulsive therapy (ECT) in treatment-resistant bipolar adolescents in Canada 
(Kutcher & Robertson, 1995) and the other a home-based social work intervention for 
children who deliberately poison themselves in the UK (Byford et al, 1999). Disease-
specific outcome measures were used and included the Brief Psychiatric Rating Scale 
(BPRS), length of stay in hospital (Kutcher & Robertson, 1995), the Suicidal Ideation 
Questionnaire (SIQ), the Hopelessness Scale and the Family Assessment Device 
(FAD), a measure of family functioning (Byford et al, 1999). Both these studies can 
be described as cost-consequences analyses, since a range of outcome measures are 
presented alongside the costs. The authors investigated broad (Byford et al, 1999) and 
narrow (Kutcher & Robertson, 1995) ranges of cost measures.  Measures of costs 
included general and specific health care costs such as inpatient care, education and 
social services.  
 
Byford et al (1999) report no significant differences between the two groups on any of 
the outcome measures used or in the total costs per patient, although the observed 
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costs appear to be lower in the social work group than the control group. Although 
this paper has a large sample size (172) in comparision to other studies in the review, 
the authors still recommend caution in interpretation given that sample size 
calculations were based on outcomes and not cost.  Kutcher & Robertson (1995) 
report significant improvement in BPRS scores and lower total costs per patient for 
those in ECT compared to those who refused treatment, although this study is limited 
by non-randomised allocation and extremely small sample sizes (22 in total). 
Economic evaluations undertaken in depressive illnesses extracted for review are not 




Two non-UK studies evaluated interventions for psychosis.  Mihalopoulous et al 
(1999) evaluated a community-oriented treatment for early onset psychosis in 
Australia, and Rund et al (1994) from Norway evaluated a psychoeducational 
intervention compared to standard care for early onset schizophrenia. Both studies 
were before-and-after studies undertaken using retrospective reviews, one looking at 
102 (Mihalopoulous et al, 1999) and the other at 24 young people (Rund et al, 1994).   
 
Outcomes were measured using psychosocial functioning, relapse rates (Rund et al, 
1994), quality of life and negative symptoms (Mihalopoulous et al, 1999). Costs were 
analysed from the perspective of the health service and included inpatient treatment, 
home visits, consultations with a private medical doctor and seminar costs for parents, 
including travel and other expenses. Both studies found lower costs for the 
experimental groups than the control groups, although there were no indications of the 
statistical significance of these differences in the papers. For the community-
orientated treatment study, outcomes were found to be better in the experimental 
group. However, for the psychoeducational intervention there were no significant 
differences between the groups on length of hospital stay and relapse rates. The 
authors conclude that the experimental interventions are cost-effective with lower 
costs and better outcomes. In common with other studies in the review these studies 
suffer from retrospective designs and small sample sizes. 
 
Developmental disorders 
Our review identified one study of the cost-effectiveness of early intervention services 
for children with developmental disorders (Erickson Warfield, 1995). The author, in a 
follow-up paper to an analysis of twenty-five publicly-supported services, suggests 
that the service identified as more cost-effective varied by sub-group and outcome 
measure. The analyses suggest that group services are more efficient than home visits, 
although the generalisability of the results is limited. 
 
Jacobson et al (1998) undertook an analysis of an early intensive behavioural 
programame for children with pervasive developmental disorder or autism. Althoigh 
the title suggests a cost-benefit analysis, the study in fact compares the cost of the 
intervention in childhood with expenditure savings in adulthood. This paper has been 
criticised for its narrowly ‘economist’ approach.  
 
Co-morbid substance use 
King et al (2000) examined the costs and outcomes of adolescents with substance use 
disorders co-morbid with other psychiatric disorders in two different service systems 
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– the Fort Bragg Demonstration project, involving a continuum of care services, and 
two comparison sites that provided traditional fee-for-service mental health services. 
Outcomes were assessed at baseline and six months later and included substance use, 
impairment level specifically attributed to substance abuse, mental and physical 
impairment, caregiver strain and global functioning. Costs included all mental health 
services provided. Total costs were almost US$40,000 (£24,873) per participant for 
the Fort Bragg Demonstration site and just over US$18,000 (£11,193) for the 
comparison sites. Outcomes were not found to be influenced by service system. The 
authors do not come to any specific conclusion regarding relative cost-effectiveness, 
but it appears that the demonstration site may be less cost-effective than the control 
sites. Any conclusion, however, must be viewed cautiously given small sample sizes 
and the possibility of bias due to the lack of randomisation or adjustment for 
differences between the two groups. 
 
Various mental health problems 
Interventions geared towards a combination of mental health problems among youth, 
including children at risk of self-harm have used cost-offset as a means of assessing 
costs in relation to savings from reductions in the utilisation of menal health services 
(Foster and Bickman, 2000), reductions in direct service hours delivered (Yates and 
colleagues, 1994), averted hospitalisation costs (Margolis and Petti, 1994; Gustafsson 
and Svendin, 1998; Blumberg and colleagues, 2002) and reduction in direct service 




As the availability of health-related interventions and technologies increases and 
society’s resources remain finite, questions of efficiency tend to be posed with 
increasing regularity in decision-making contexts. This is often the prompt for 
economic evaluations.  A previous review conducted in 1997 suggests few economic 
evaluations of poor quality. As this review has demonstrated the situation has not 
improved markedly. Only 14 full economic evaluations were found suggesting the 
number undertaken remains small.  
 
We found a number of descriptive cost studies that provide useful background and 
other data but cannot be seen as evaluative in that they do not measure outcomes. For 
example, Beitchman et al (1992) investigate the factors impinging on costs and argue 
that the disorders which consume the most resources should be the focus of early 
intervention.  However, because this form of analysis ignores outcomes, and 
specifically the relative marginal benefits of alternative ways of spending the same 
fixed resources, it ought not to be seen as the (sole) basis for allocation decisions. A 
high cost disorder or behavioural problem may well - rightly - attract a lot of attention 
and generate much concern, but high cost alone cannot provide a basis for resource 
allocation. 
 
The review also identified a number of cost-offset studies. These studies provide 
estimates of savings to health and non-health sectors as a result a mental health 
interventions. Though the measures of costs and outcomes (where they were 
measured) differ across studies, all of the studies indicated some level of savings as a 
result of the intervention. However, because each study is context - and country - 
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specific it is difficult to know how far it is possible to generalise the findings: the 
results are indicative. 
 
Economic evaluations conducted in this field have focused on service-based 
interventions and their location as opposed to interventions directed to managing the 
illness. There has only been one study to date which has evaluated the cost-
effectiveness of a drug treatment for children with mental health problems (Gilmore 
& Milne, 2001). This is no doubt due in part to the small market for drug treatment 
for children compared to adults (Knapp, 1997). There have been more - but still 
disappointingly few - economic evaluations of behavioural therapies for children and 
adolescents, particularly for behavioural disorders. 
 
What also becomes apparent from this review are the methodological limitations 
common to most of the economic evaluations which could lead to invalid and biased 
decisions. Problems include small sample sizes that limit the power to detect 
significant differences, decision analysis or other models based on spurious, dubious 
or untested assumptions, and limited statistical and econometric methods (recent 
advances in statistical methods applied to economic evaluations has made less recent 
studies appear to lack robustness). Evaluations were mainly undertaken from just the 
provider perspective, resulting in a narrow conceptualisation of costs that may fail to 
uncover all important society-wide impacts of an intervention. 
 
Cost-effectiveness analysis, employing disease-specific measures of outcome, was the 
most widely used method of economic evaluation in the area of child and adolescent 
mental health. This is not surprising given the wide range of outcome measures to be 
analysed in mental health and the comparative ease with which economic evaluations 
can be attached to a clinical study. There has been little use of incremental cost-
effectiveness ratios in the CAMHS field, even though this has been standard health 
economics practice in many other clinical fields for some time. Nor has there been 
much exploration of QALYs, within cost-utility analyses. This is perhaps due to 
conceptual and methodological difficulies in translating measures of outcome into 
generic health-related quality of life measures.  More generally, too few clinical 




General awareness of the need to focus health and social care decision-making on 
cost-effectiveness analyses, has prompted calls for economic evaluations of 
competing interventions in a number of areas.  The area of child and adolescent 
mental health is no exception. There is, without doubt, heightened awareness among 
policy makers of the need for evidence-based information to guide policy and practice 
for children and adolescents with mental health problems. But there is also a widely 
recognised paucity of solid evidence. In this paper, we have reported the results of our 
search for economic evaluative data - the kinds of findings that could and should 
inform resource allocation decisions. What we have found has been disappointing but 
perhaps not surprising. Given the varied nature of mental health problems and mental 
health interventions, and the small number of economic evaluations undertaken it is 
difficult to come to any firm policy conclusions.  
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Our systematic review found that most of the economic studies focused on 
behavioural disorders or antisocial behaviour which are highlighted as clinical and 
social problems across many countries. Within this diagnostic group most of the 
studies compared the location of service provision, although location, forms of the 
intervention and methodologies used differed significantly across studies. 
Interventions for depressive disorders, psychosis, developmental disorders and co-
morbid substance use were all examined using cost-effectiveness analysis, but again 
there were few such studies. 
 
On the brighter side, the situation has improved since a somewhat less systematic 
review conducted a few years ago (Knapp, 1997). Over the last five or six years, there 
has been more awareness of the need for this evaluative perspective, and more 
discussion about the methodological needs for good research. More sophisticated and 
robust techniques are being employed.  At our own centre - Centre for the Economics 
of Mental Health, at the Institute of Psychiatry staff are undertaking research in a 
wide spectrum of childhood mental health disorders. An economic evaluation of 
group versus individual psychotherapy for sexually abused girls has recently been 
completed. An investigation of the service use and costs for adults who were treated 
for childhood depression is underway. An assessment of the cost-effectiveness and 
cost-utility of fluoxetine and cognitive-behaviour therapy versus fluoxetine alone in 
adolescents with persistent major depression is also being undertaken. Other studies 
include an evaluation of the cost-effectiveness of specialist inpatient treatment, 
specialist outpatient treatment and general management in child and adolescent 
mental health services for adolescents with anorexia nervosa and a quantitative survey 
and qualitative case study analysis to determine the effectiveness of mental health 
provision for young people in custody and in the community. We are also aware of 
research in the US and other countries that will contribute importantly to solid 
economics evidence base for child and adolescent mental health policy and practice. 
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Table 1 
STRUCTURED SUMMARIES AND COMMENTARIES 
 
First author  Type of 
evaluation 




Cost offset  Problem 
behaviours 
School social work 
intervention  
Cost of school exclusions Cost of exclusion unit, 
home tuition and project 
workers 
There was a statistically significant reduction in the 
rates of self-reported theft, truancy, bullying and net 
exclusions. Analysis of the reduction in school 
exclusion showed a net benefit to the project of 




Cost offset  Children at risk 






Cost of hospitalisation  Treatment costs   In comparison to an historical control group, the 
programme resulted in a 23% reduction in the use of 
psychiatric treatment beds. The crisis intervention 








Home-based social work 
intervention plus routine 
care versus routine care 
alone 
Suicidal ideation, 
hopelessness and family 
functioning 
Cost of all health, 
education and social 
services 
No significant differences between the two groups in 
terms of the main outcome measures or costs. In a 
sub-group of children with major depression, 
suicidal ideation was significantly lower in the 
intervention group at the six-month follow-up with 








Individual therapy, group 





reported behaviour and 
observed behaviour 
Professional time  MCB was the least costly in terms of professional 
time and was equally effective in terms of parental 









Community based group 
training programme 
versus clinic based 
individual intervention  
Adherence, behaviour 
problems at home, 
problem solving skills, 
parenting sense of 
competence, parenting-
child interactions.   
Cost of training 
programmes 
Parents in the community groups reported greater 
improvements in behaviour problems than the clinic 
participants. Costs were similar between the two 
groups - CAN $5.42 per participant for clinic based 














versus centre-based group 
early intervention 
services 
Child social competence, 
mother-child interaction 
and parenting stress 
Treatment costs  The service identified as most cost-effective was 




Cost offset  Mental health 
problems 
Continuum of care (Fort 
Bragg) 
Cost of services used 
outside of the Fort Bragg 
Demonstration 
Cost of services provided 
as part of the Fort Bragg 
Demonstration 
Reductions in other costs do partially offset higher 
expenditures on mental health services for children at 
the Fort Bragg Demonstration, but the Demonstration 
site remains more costly than comparison sites. 
  1505 July 2005 
 
First author  Type of 
evaluation 




Cost utility   Hyperactivity  Methylphenidate versus 
placebo 
Quality adjusted life 
years (QALY) 
Health service costs  Methylphenidate generated a reasonable cost 









Day treatment versus 
residential treatment  
Degree of school 
integration and clinical 
improvement 
Treatment costs  The average cost of treating children at the residential 
unit decreased when the unit was converted to a day 
treatment facility. Clinical outcomes and the degree of 






Cost offset  Psychosomatic 
or somatic 
disorders 
Family therapy  Cost of inpatient stays  Cost of treatment  Hospitalisation days decreased more in treated groups 
than controls. Total cost of treatment was offset by 











Child’s behaviour and 
parental perceptions of 
parenting problems 
Cost of health, education, 
social services, voluntary 
and private sector 
services 
There was no significant difference between the two 




Cost offset  Autism   Early intensive 
behavioural intervention 
(EIBI) 
Cost savings into 
adulthood 
Service costs, social 
security and net earnings 
Cost savings range from $187,000 to $203,000 per 
child for people aged 3-22 years and from $656,000 to 
$1,082,000 per people aged 3 – 55 years. Differences 






and cost offset 
Poor children at 




Costs of crime, criminal 
charges, security reports, 
fire calls 
Programme costs  Potential savings were found to exceed the cost of 









substance use  
Continuum of care (Fort 
Bragg) versus traditional 




Treatment costs  Mental health outcomes not influenced by type of 
service system. Demonstration site costs were 










treatment versus standard 
pharmacological inpatient 
care 
Symptom severity and 
side-effects 
Cost of hospitalisation  Outcomes were significantly better and hospitalisation 
costs lower in the ECT group than the ECT refusing 
group.   
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First author  Type of 
evaluation 




Cost offset  Various  Intensive home based 
service versus increased 
remuneration for 
providers of community 
based placements 
Averted hospital costs  Cost of intensive home 
based services, cost for 
increased remuneration 
strategy  
Analysis of costs and benefits of intensive home 
based services produced a favourable cost-offset ratio 
of  0.47. Analysis of the strategy to increase 
remuneration for providers of community-based 
placements resulted in a cost-offset ratio of 1 






Psychosis    Early  psychosis
prevention (EPPIC) 
versus precursor service 
Psychosocial functioning 
and negative symptoms 
Cost of health and other 
services 
EPPIC was shown to be more cost-effective.  The 
weighted average cost per patient for the first 12 













Treatment and social 
welfare service costs 
The psychoeducational programme was more 
effective in terms of relapse and cheaper. Patients 
with poor premorbid psychosocial functioning were 















Residential centre costs  Outcomes were poorer for the community 
intervention compared to the state institute, but costs 








Parent training versus 
waiting list controls 
Parents’ perception of 
child's behaviour, parent's 
sense of competence and 
family satisfaction 
Cost of staff time  Treatment parents recorded significantly greater 
improvements in child behaviour problems, parent 
attitudes and satisfaction with family relationships 
when compared to untreated controls. The direct cost 




Cost offset  Various  Six methods of 
motivating  therapists to 
meet service delivery 
goals 
Cost savings in terms of 
therapist hours 
Cost of incentive 
intervention 
Four incentive interventions generated greater cost 
savings than they required in monetary outlays.  The 
most cost beneficial intervention was payment of 
bonuses to therapists for exceeding their goals 
alongside staff rewards if total department goals were 
exceeded. 
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Box 1 
A 10-point checklist to assess the quality of an economic evaluation 
 
 
1.  Was a well-defined question posed in answerable form? 
 
Did the study examine both the costs and effects of the service(s) or programme(s)? 
Did the study involve a comparison of alternatives? 
Was a viewpoint for the analysis stated and was the study placed in any particular 
decision-making context? 
 
2.  Was a comprehensive description of the competing alternatives given (i.e., 
can you tell who did what to whom, where, and how often)? 
 
Were any important alternatives omitted? 
Was (Should) a do-nothing alternative (be) considered? 
 
3.  Was the effectiveness of the programme or service established? 
 
Was this done through randomised, controlled clinical trial? If so, did the trial 
protocol reflect what would happen in regular practice? 
Was effectiveness established through an overview of clinical studies? 
Were observational data or assumptions used to establish effectiveness? If so, what 
are the potential biases in results? 
 
4.  Were all important and relevant costs and consequences for each alternative 
identified? 
 
Was the range wide enough for the research question at hand? 
Did the costs cover all relevant viewpoints?  (Possible viewpoints include the 
community or social viewpoint, and those of patients and third party payers. Other 
viewpoints may also be relevant depending upon the particular analysis.) 
Were capital cost, as well as operating cost, included? 
 
5.  Were costs and consequences measured accurately in appropriate physical 
units? (e.g. hours of nursing time, number of physician visits, lost work-days, 
gained life-years) 
 
Were any of the identified items omitted from measurement?  If so, does this mean 
that they carry no weight in the subsequent analysis? 
Were there any special circumstances (e.g., joint use of resources) that made 
measurement difficult? Were these circumstances handled appropriately? 
 
6.  Were cost and consequences valued credibly?   
 
Were the sources of all values clearly identified?  (Possible sources include market 
values, patient or client preferences and views, policy-makers’ views and health 
professionals’ judgements.) 
 
Were market values employed for changes involving resources gained or depleted? 
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Where market values were absent (e.g., volunteer labour), or market values do not 
reflect actual values (such as clinic space donated at a reduced rate), were adjustments 
made to approximate market values?. 
Was the valuation of consequences appropriate for the question posed (i.e. has the 
appropriate type or types of analysis – cost-effectiveness, cost-benefit, cost-utility – 
been selected)? 
 
7. Were costs and consequences adjusted for differential timing?    
 
Were costs and consequences which occur in the future ‘discounted’ to their present 
values? 
Was any justification given for the discount rate used? 
 
8.  Was an incremental analysis of costs and consequences of alternatives 
performed? 
 
Were the additional  (incremental) costs generated by one alternative  over another 
compared to the additional effects, benefits or utilities generated? 
 
9.  Was a sensitivity analysis performed? 
 
If data on costs and consequences were stochastic, were appropriate statistical 
analyses performed? 
If a sensitivity analysis was employed, was a justification provided for the ranges of 
values (for key study parameters)? 
Were the study results sensitive to changes in the values (within the assumed range 
for sensitivity analysis, or within the confidence interval around the ratio of costs to 
consequences)? 
 
10. Did the presentation and discussion of study results include all issues of 
concern to users? 
 
Were the conclusions of the analysis based on some overall index or ratio of costs to 
consequences (e.g., cost-effectiveness ratio)? If so, was the index interpreted 
intelligently or in a mechanistic fashion? 
Were the results compared with those of others who have investigated the same 
question? If so, were allowances made for potential differences in study 
methodology? 
Did the study discuss the generaliseability of the results to other settings and 
patient/client groups? 
Did the study allude to, or take account of, other important factors in the choice or 
decision under consideration (e.g., distribution of costs and consequences, or relevant 
ethical issues)? 
Did the study discuss issues of implementation, such as the feasibility of adopting the 
‘preferred’ programme given existing financial or other constraints, and whether any 
freed resources could be redeployed to other worthwhile programmes? 
 
Source: Drummond et al (1997) 
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Summary criteria for assessing quality of cost effectiveness studies ( possible 
alternative to Box1) 
 
•  Inclusion of focused study question  
•  Inclusion of statement on viewpoint of analysis 
•  Was there a clear description of of comparators? 
•  Effectiveness of interventions established 
•  Were all relevant cost and outcomes identified for each alternative 
•  Were these cost and outcomes measured and valued plausibly 
•  Were cost and outcomes discounted? 
•  Inclusion of sensitivity analysis 
•  Incremental approach to analysis of costs and effects used 
•  How appropriate is the analysis to users? 
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